Financial statements Biosys
Balance sheet data of BIOSYS
|
Year
|
2017
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 1 448 140,55 | 2 421 317,47 | 2 734 492,39 | 2 536 014,10 | 5 032 769,44 | 7 093 214,46 |
| A. Fixed assets | 10 834,16 | 10 834,16 | 10 834,16 | 10 834,16 | 84 990,21 | 1 161 941,96 |
| B. Current assets | 1 437 306,39 | 2 410 483,31 | 2 723 658,23 | 2 525 179,94 | 4 947 779,23 | 5 931 272,50 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 1 448 140,55 | 2 421 317,47 | 2 734 492,39 | 2 536 014,10 | 5 032 769,44 | 7 093 214,46 |
| A. Equity | 1 080 542,19 | 1 532 086,18 | 1 601 942,47 | 1 941 829,96 | 3 789 283,29 | 5 697 888,52 |
| B. Liabilities and provisions for liabilities | 367 598,36 | 889 231,29 | 1 132 549,92 | 594 184,14 | 1 243 486,15 | 1 395 325,94 |
| I. Long-term liabilities | 0,00 | 0,00 | - | 0,00 | - | 0,00 |
| II. Short-term liabilities | 318 486,19 | 400 648,08 | 669 840,97 | 474 239,11 | 986 888,00 | 1 272 701,19 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.